hidesy-shutterstock-com-1

hidesy / Shutterstock.com

24 September 2015Big PharmaAnja Lunze and Paul England

SPCs: When a few days makes a difference

On September 10, Advocate-General (AG) Niilo Jääskinen delivered his opinion in a case concerning supplementary protection certificates (SPCs). The case (C-471/14) was brought by Seattle Genetics against the Austrian Patent Office (APO).

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

Life sciences leaders recognised at LSPN Awards USA 2025

LSPN: Counsel grapple with AI’s impact on training and critical thinking

LSPN: Trump's policy storm causing chaos and confusion

Taylor Wessing expands in Europe with Paris team

LSPN: Using ‘the patentee’s friend’ in Section 112 claims

Novartis settles with licensee of blood cancer therapy day before trial

Foley adds five-partner team from Perkins Coie and K&L Gates

UPC orders 17-country ban on EOFlow's pumps in Insulet feud